A REVIEW ON FLOATING TYPE GASTRORETENTIVE DRUG DELIVERY SYSTEM

Oral controlled release delivery systems are programmed to deliver the drug in predictable time frame that will increase the efficacy and minimize the adverse effects and increase the bioavailability of drugs. Oral route is considered mostnatural, uncomplicated, convenient and safe due to its ease of administration, patient acceptance, and cost-effective manufacturing process.Floating Drug delivery system are designed to prolong the gastric residence time after oral administration, at particular site and controlling the release of drug especially useful for achieving controlled plasma level a swell as improving bioavailability Several approaches are currently being used to prolong the GRT, including floating drug delivery systems (FDDS), also known as hydrodynamically balanced systems (HBS), swelling and expanding systems, high-density systems, and other delayed gastric emptying devices

[1]  A. Hoffman,et al.  Expandable gastroretentive dosage forms. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[2]  I. Whelan,et al.  Development and validation of an in vitro dissolution method for a floating dosage form with biphasic release characteristics , 1995 .

[3]  Juergen Siepmann,et al.  Gastroretentive drug delivery systems , 2006, Expert opinion on drug delivery.

[4]  K. Amighi,et al.  Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. , 2007, International journal of pharmaceutics.

[5]  Vishnu Patel,et al.  FLOATING DRUG DELIVERY SYSTEM: INNOVATIVE APPROACH OF GASTRORETENTION , 2010 .

[6]  L. Balant,et al.  Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. , 1998, Pharmaceutica acta Helvetiae.

[7]  Sanford Bolton,et al.  A Floating Controlled-Release Drug Delivery System: In Vitro-in Vivo Evaluation , 1993, Pharmaceutical Research.

[8]  J. Timmermans,et al.  Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. , 1994, Journal of pharmaceutical sciences.

[9]  V. Pillay,et al.  Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[10]  G. Digenis,et al.  An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations☆ , 1997 .

[11]  C. Rhodes,et al.  Development of a Novel Controlled-Release System for Gastric Retention , 1997, Pharmaceutical Research.

[12]  Brahma N. Singh,et al.  Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[13]  P. Yeole,et al.  Studies on formulation and evaluation of ranitidine floating tablets , 2005 .

[14]  Tsuneji Nagai,et al.  Preparation of a magnetically-responsive tablet and confirmation of its gastric residence in beagle dogs , 1994 .

[15]  J. Fell,et al.  Development of a gastroretentive dosage form. , 1996 .

[16]  Ira,et al.  Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.

[17]  J. Siepmann,et al.  Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. , 2003, Journal of microencapsulation.

[18]  Parviz Mojaverian,et al.  Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations , 1988, Pharmaceutical Research.

[19]  P. Deasy,et al.  In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate , 1992 .

[20]  Javed Ali,et al.  Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.

[21]  R. Garg,et al.  Progress in Controlled Gastroretentive Delivery Systems , 2008 .

[22]  Deepika Sharma,et al.  FLOATING SYSTEMS: A NOVEL APPROACH TOWARDS GASTRORETENTIVE DRUG DELIVERY SYSTEMS , 2010 .

[23]  A. Pawar,et al.  Low density multiparticulate system for pulsatile release of meloxicam. , 2006, International journal of pharmaceutics.

[24]  Kinam Park,et al.  Enzyme-digestible swelling hydrogels as platforms for long-term oral drug delivery: synthesis and characterization. , 1988, Biomaterials.